The Serum Institute of India will soon manufacture a vaccine for the Ebola infection spread in Uganda. The company plans to manufacture 20,000 to 30,000 doses by the end of November, which will be administered as a trial against the Ebola infection spread in Uganda.
Serum Institute of India will soon start clinical trial of vaccine for Ebola infection spread in Uganda. The company plans to manufacture 20,000 to 30,000 doses by the end of November, which will be administered as a trial against the Ebola infection spread in Uganda.
54 cases of Ebola confirmed in Uganda
Let us inform that since last month 54 cases have been confirmed due to Ebola infection in Uganda and 19 people have died due to this. The first case was reported in the capital Kampala last week. Although health officials believe that the actual number may be higher.
The initial response to the vaccine was better
Let us tell you that the Jenner Institute of Oxford University is developing an Ebola vaccine, which has shown good response in both the Sudan and Zaire strains in the first phase. The vaccine manufacturer said that after getting regulatory approval in Uganda, its clinical trial can be done.
Vaccine manufacturing work going on fast
Teresa Lambe, chief scientific adviser working on the Ebola vaccine at the Jenner Institute, said, “We are working closely with the Serum Institute to accelerate the development of this vaccine.” We are expecting to have a large number, around 20,000 to 30,000 or more doses ready by the end of November.
Ebola vaccine will be provided for free
This news, quoted by Reuters, has been confirmed by a source at Serum Institute, the world’s largest vaccine manufacturer. He said that the dose of Ebola vaccine would be provided free of cost. However, Ugandan Information Minister Chris Baryomunsi told in an interview on Saturday that he had no information about this vaccine manufacturing. He said that Ebola infection is now under control in Uganda.